Trade FRNM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Freenome, Inc. (FRNM) is trading at US$13.22, down 16.22% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$1.47B. Over the past 52 weeks, FRNM has traded between US$9.95 and US$17.50. On Syfe you can trade FRNM with $0 commission and add it to your watchlist.
| Previous close | US$15.78 |
|---|---|
| Market cap | US$1.47B |
| 52-week range | US$9.95 – US$17.50 |
| Volume | 1.57M |
| Exchange | US |
Freenome, Inc.
Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.
Year: 2026
--Guggenheim Initiates Freenome at Buy With $21 Price Target
Aug 20, 10:55 AM · MT Newswires
Freenome Registers Up To 75.2 Million Shares For Sale
Aug 18, 9:19 PM · MT Newswires
--TD Cowen Initiates Freenome at Buy With $17 Price Target
Aug 18, 10:12 AM · MT Newswires
Sector Update: Healthcare Stocks Softer Late Afternoon
Aug 17, 8:02 PM · MT Newswires
Freenome, Inc. (FRNM) stock is trading at US$13.22, -16.22% from the previous close of US$15.78.
The market cap for Freenome, Inc. (FRNM) stock is approximately US$1.47B.
The 52-week high for Freenome, Inc. (FRNM) stock is US$17.50.
The 52-week low for Freenome, Inc. (FRNM) stock is US$9.95.
Freenome, Inc. (FRNM) does not currently pay a dividend.
Stay on top of FRNM
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
